Patent · US Active

Compositions and methods for treatment of neoplastic disease

US7803637B2 · kind B2 · utility

1Cited by
0References
2Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJun 25, 2008
Grant dateSep 28, 2010
Priority date
Expiry dateJan 15, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/33
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention comprises the use of sickle cells or sickle cell precursors loaded with a therapeutic agent that localizes in tumors and induces a tumoricidal response.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.